This message was sent to ##Email##
Advertisement
|
|
|
|

Don’t miss Dr. Orlando’s Invited Session, Transplant Medicine in the XXI Century: A Traditionally Immunology-Based Discipline Destined to Become Regenerative Medicine-Based at the ITNS Symposium. Register before 16 October to save $100! Learn more and register today!

The Transplant Nursing Symposium in Orlando, FL, USA will be here before you know it! Please consider nominating a colleague for an ITNS award.
Transplant Nursing Excellence Award: Recognizes an exemplary nurse (RN or equivalent) for their care of transplant patients and their embodiment of the ITNS mission and values.
Friend of Transplant Nursing Award: Recognizes an individual outside the nursing profession who has supported the efforts of ITNS and made an impact in the field of transplant nursing.
All nominations must be received by Aug. 30, 2019.
Thursday, Nov. 14 from 07:00 - 17:30
10.5 Contact Hours
Sandra Cupples, PhD RN FAAN; Linda Ohler, RN MSN CCTC FAAN FAST
This one-day, face-to-face CCTC and CCTN review course, presented by Sandra Cupples, PhD RN FAAN and Linda Ohler, RN MSN CCTC FAAN FAST, is a comprehensive program for transplant nurses preparing for the CCTC and CCTN examinations. Based on the American Board for Transplant Certification’s test blueprints and the 2nd edition of the Core Curriculum for Transplant Nurses, this course includes general transplantation and organ-specific topics as well as information on test-taking strategies. Participants will earn 10.5 CEU or CEPTC credits. Learn more and sign up today to reserve your seat!
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
Modern Healthcare
The CMS is eying a potentially massive regulatory overhaul for the two big players in organ transplants: the regional contractors that procure and distribute organs for transplant and the transplant centers themselves.
The agency's announcement was embedded in an 800-page hospital regulatory proposal released on July 26. It came as a sign that the Trump administration will continue working on the highly political and contentious policy issue that is the nation's organ allocation system.
READ MORE
Thomas Network
While every winter you may consider traveling somewhere warm to avoid the cold weather or staying inside and hibernating like many species native to cold winters, the North American wood frog will welcome the cold with open arms. The amphibian gradually lets up to 65 percent of its body completely freeze for the winter months.
The outside of the frog appears completely solid in this state, but it's not dead. When the ice starts to thaw, so will the frog; its heart will restart and the frog will hop away without batting an eye. This reanimation process, which is unique to this species of frog, has both stumped and amazed scientists for years. Researchers are investigating this survival technique for various medical applications, including cryogenics and the preservation of organs during transplant. Medical professionals hope to copy these freezing abilities to potentially add days to the preservation of human organs.
READ MORE
Chronogram
The idea of "bioprinting" human tissues and organs has been around for a few years, and some researchers and entrepreneurs are pouring their efforts into what seems like a far-out yet promising notion. The implications are mind-blowing, because if we print individualized organs from our own cells, we can solve many problems in the fields of organ transplantation and regenerative medicine. Gone will be the problem of donor-kidney shortages (there are currently about 96,000 Americans on a kidney donor waitlist, and 13 people with kidney failure die every day waiting for an organ). We could also avoid immunosuppressive drugs, because the body would have no reason to reject tissues made from its own cells.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn More
|
Clinical Transplantation
Multimorbidity and therapeutic complexity are a recognized problem in the heart transplant population. However, little is known about how best to quantify this complexity or the strategies that could reduce its burden.
READ MORE
KU Leuven via ScienceDaily
A group of scientists has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies. The identification can be done through a simple blood test and at an early stage. It is the first known biomarker for rejection by antibodies. The researchers hope that the test can be further developed quickly for use in the hospital.
READ MORE
AJMC
Amyloidosis may impact long-term survival rates of patients receiving kidney transplants, according to a new study, which found that patients who had end-stage renal disease secondary to amyloidosis had poorer survival rates compared with patients with kidney disease secondary to other causes.
READ MORE
AASLD
Cardiovascular disease is a major contributor to long‐term mortality after liver transplantation necessitating aggressive modification of CVD risk. However, it is unclear how coronary artery disease and development dyslipidemia following LT impacts clinical outcomes and how management of these factors may impact survival.
READ MORE
JHLT
The purpose of this study was to examine outcomes and survival with mechanical ventilation and extracorporeal membrane oxygenation as a bridge to lung transplantation using a national registry.
READ MORE
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|